Cargando…

Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia

We describe a 42-year old woman, admitted to our Department after 15 days of persistence of respiratory failure and treated with infusion of intravenous immunoglobulin with a successful outcome.

Detalles Bibliográficos
Autores principales:	Lanza, Maurizia, Polistina, Giorgio Emanuele, Imitazione, Pasquale, Annunziata, Anna, Di Spirito, Valentina, Novella, Carannante, Fiorentino, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229478/ https://www.ncbi.nlm.nih.gov/pubmed/32426229 http://dx.doi.org/10.1016/j.idcr.2020.e00794

Ejemplares similares

Daytime alternatives for non-invasive mechanical ventilation in neuromuscular disorders
por: Annunziata, Anna, et al.
Publicado: (2021)

A Rare Evolution to Pneumopericardium in Patient with COVID-19 Pneumonia Treated with High Flow Nasal Cannula
por: Polistina, Giorgio Emanuele, et al.
Publicado: (2021)

Effectiveness of corticosteroids on chest high-resolution computed tomography features of COVID-19 pneumonia
por: Calabrese, Cecilia, et al.
Publicado: (2021)

Home Management of Patients with Moderate or Severe Respiratory Failure Secondary to COVID-19, Using Remote Monitoring and Oxygen with or without HFNC
por: Annunziata, Anna, et al.
Publicado: (2021)

Diagnosis and treatment of pneumonia, a common cause of respiratory failure in patients with neuromuscular disorders
por: Carannante, Novella, et al.
Publicado: (2021)

Only those who attempt the absurd will reach the impossible. High-flow nasal cannula oxygen therapy alone during weaning after extubation in a patient with tuberous sclerosis complex and lymphangioleiomyomatosis
por: Lanza, Maurizia, et al.
Publicado: (2020)

Unconventional use of high-flow nasal cannula in acute exacerbation of idiopathic pulmonary fibrosis with high levels of hypercapnia
por: Fiorentino, Giuseppe, et al.
Publicado: (2020)

Late Reactivation of SARS-CoV-2: A Case Report
por: Coppola, Antonietta, et al.
Publicado: (2020)

The Role of High Flow Nasal Cannula in COVID-19 Associated Pneumomediastinum and Pneumothorax
por: Simioli, Francesca, et al.
Publicado: (2021)

Alpha-1 Antitrypsin Screening in a Selected Cohort of Patients Affected by Chronic Pulmonary Diseases in Naples, Italy
por: Annunziata, Anna, et al.
Publicado: (2021)

Acute Pancreatitis and COVID-19: A Single-Center Experience
por: Annunziata, Anna, et al.
Publicado: (2021)

Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series
por: Simioli, Francesca, et al.
Publicado: (2021)

Long-Term High Flow Nasal Cannula Therapy in Primary and Secondary Bronchiectasis
por: Simioli, Francesca, et al.
Publicado: (2023)

Usefulness of the HACOR score in predicting success of CPAP in COVID-19-related hypoxemia
por: Guia, Miguel Filipe, et al.
Publicado: (2021)

Intermittent Abdominal Pressure Ventilation: An Alternative for Respiratory Support
por: Fiorentino, Giuseppe, et al.
Publicado: (2021)

Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report
por: Carannante, Novella, et al.
Publicado: (2020)

Remdesivir in Severe COVID-19 and Non-Invasive Ventilation: A Real-Life Experience
por: Simioli, Francesca, et al.
Publicado: (2021)

Alpha-1 antitrypsin deficiency in the elderly: a case report
por: Annunziata, Anna, et al.
Publicado: (2021)

Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure. A single-centre case series
por: Simioli, Francesca, et al.
Publicado: (2020)

Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives
por: Fiorentino, Giuseppe, et al.
Publicado: (2018)

The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department
por: Annunziata, Anna, et al.
Publicado: (2021)

Alpha-1 Antitrypsin Deficiency: Home Therapy
por: Annunziata, Anna, et al.
Publicado: (2021)

ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role
por: Calabrese, Cecilia, et al.
Publicado: (2021)

Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin
por: Güngör, Cansu, et al.
Publicado: (2020)

Aerosol delivery through high-flow nasal therapy: Technical issues and clinical benefits
por: Calabrese, Cecilia, et al.
Publicado: (2023)

The role of dexmedetomidine in ARDS: an approach to non-intensive care sedation
por: Simioli, Francesca, et al.
Publicado: (2023)

Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins
por: Godani, Massimiliano, et al.
Publicado: (2022)

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
por: Xie, Yun, et al.
Publicado: (2020)

Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
por: Olson, Rose M., et al.
Publicado: (2018)

Adult Krabbe Disease That Was Successfully Treated with Intravenous Immunoglobulin
por: Fukazawa, Ryosuke, et al.
Publicado: (2020)

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
por: Tatar, Erhan, et al.
Publicado: (2020)

Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023)

Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
por: Higo, Hisao, et al.
Publicado: (2022)

Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
por: Dolenc-Voljč, M., et al.
Publicado: (2013)

Successful Use of Intravenous Immunoglobulins in an Obinutuzumab-related Acute Thrombocytopenia
por: Haage, Tobias R., et al.
Publicado: (2022)

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
por: Liu, Xiaosheng, et al.
Publicado: (2020)

Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
por: Shah, Nihar, et al.
Publicado: (2014)

Case report: A case of severe retropharyngeal edema after COVID-19 successfully treated with intravenous immunoglobulin
por: Suzuki, Takanori, et al.
Publicado: (2023)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_g4pqla4gu5eiqageqj85ucspel